We are excited to announce that the CareStart™ COVID-19 Antigen Home Test has recently joined the list of COVID-19 rapid antigen self-tests (home use tests) approved by TGA.

CareStart™, already used widely by corporates and government departments under the supervision of healthcare practitioners, is one of the fastest rapid antigen tests on the market, providing you with results

and peace of mind in just 10-minutes. Manufactured in the USA, CareStart™ has been locally and internationally validated for its accuracy through extensive clinical trials.

With Australia opening up and finally putting lockdowns behind us, rapid antigen self-tests are a tool that provide on-the-spot, quick and easy screening against COVID-19 and will allow us to safely and confidently return to life as we once knew it.

Our Director, Sally Panton, welcomed the TGA approval of the CareStart™ COVID-19 Antigen Home Test as an important step towards further enhancing community safety.

“Pantonic wholeheartedly supports the Government’s strategy centring around getting Australians vaccinated and views rapid antigen testing as an important complementary measure that the public can take to contribute to keeping the entire community safe, sitting alongside masks, QR code check-ins and social distancing.”

“The at home rapid antigen test will be complementary to the supervised point of care rapid antigen tests which Pantonic has successfully implemented with a large number of tier one Corporates and Government agencies in Australia throughout the pandemic,” she continued.

The home tests have been designed with the untrained and unsupervised users in mind, ensuring the packaging and instructions leave no room for misinterpretation. The home tests are to be used in conjunction with the gold standard PCR tests to enforce Australia’s public health response to the COVID-19 pandemic.